Urology Medical News about Bladder

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Intravesical Liposome Versus Oral Pentosan Polysulfate for Interstitial Cystitis/Painful Bladder Syndrome
The Journal of Urology, 09/17/09

Chuang YC et al. – Each glycosaminoglycan directed treatment seemed beneficial. Liposome intravesical instillation is safe for interstitial cystitis/painful bladder syndrome with potential improvement after 1 course of therapy for up to 8 weeks. Intravesical liposomes achieved efficacy similar to that of oral pentosan polysulfate sodium. Intravesical liposomes appear to be a promising new treatment for interstitial cystitis/painful bladder syndrome.

<< Previous
Initial Experience With Robot Assisted Partial Nephrectomy for...

Next >>
Botulinum Toxin A for Overactive Bladder and Detrusor Muscle...

The importance of bladder wall thickness in the assessment of overactive bladder
Current Bladder Dysfunction Reports, 11/13/09 Relevance Score: 93%

192R Allele of Paraoxanase 1 (PON1) Gene as a New Marker for Susceptibility to Bladder Cancer
Anticancer Research, 11/10/09 Relevance Score: 91%

Significant Association of XPD Codon 312 Single Nucleotide Polymorphism with Bladder Cancer Susceptibility in Taiwan
Anticancer Research, 11/10/09 Relevance Score: 91%

Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09 Relevance Score: 91%

Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09 Relevance Score: 91%